title: Response to Crizotinib in a Patient With Lung Adenocarcinoma Harboring a MET Splice Site Mutation.
authors.affiliation: Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Russell W
authors.initials: RW
authors.lastname: Jenkins
authors.affiliation: Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Geoffrey R
authors.initials: GR
authors.lastname: Oxnard
authors.affiliation: N-of-One Inc, Lexington, MA.
authors.forename: Sheryl
authors.initials: S
authors.lastname: Elkin
authors.affiliation: N-of-One Inc, Lexington, MA.
authors.forename: E Kelly
authors.initials: EK
authors.lastname: Sullivan
authors.affiliation: N-of-One Inc, Lexington, MA.
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Carter
authors.affiliation: Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: dbarbie@partners.org.
authors.forename: David A
authors.initials: DA
authors.lastname: Barbie
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D000077192:Adenocarcinoma of Lung; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000077547:Crizotinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008297:Male; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D022821:RNA Splice Sites; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D022821:RNA Splice Sites; D000077547:Crizotinib; D019859:Proto-Oncogene Proteins c-met
keywords: Crizotinib; Lung adenocarcinoma; MET; Splice site mutation